Severity of COVID-19 in patients with lung cancer: evidence and challengesAntonio Passaro, Christine Bestvina, Maria Velez Velez, Marina Chiara Garassino, Edward Garon, Solange Peters
18 March 2021
Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemicRenee N Donahue, Jennifer L Marté, Meghali Goswami, Nicole J Toney, Yo-Ting Tsai, James L Gulley, Jeffrey Schlom
11 March 2021
Perspectives on COVID-19 and cancer immunotherapy: a review seriesJason D Goldman, Paolo Antonio Ascierto
9 March 2021
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective studyMario Mandala, Paul Lorigan, Matilde De Luca, Andrea Bianchetti, Barbara Merelli, Anna Cecilia Bettini, Lucia Bonomi, Sharon Nahm, Maria Grazia Vitale, Giorgia Negrini, Andrea Di Croce, Paolo Antonio Ascierto, Eliana Rulli, Carlo Alberto Tondini
16 February 2021
COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case reportAngelo Dipasquale, Pasquale Persico, Elena Lorenzi, Daoud Rahal, Armando Santoro, Matteo Simonelli
11 February 2021
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibitionAljosja Rogiers, Ines Pires da Silva, Chiara Tentori, Carlo Alberto Tondini, Joseph M Grimes, Megan H Trager, Sharon Nahm, Leyre Zubiri, Michael Manos, Peter Bowling, Arielle Elkrief, Neha Papneja, Maria Grazia Vitale, April A N Rose, Jessica S W BorgersSee the full list of authors
19 January 2021
Management of immune checkpoint therapy for patients with cancer in the face of COVID-19Chen Shen, Qianru Li, Yongchang Wei, Yuting Li, Jun Li, Juan Tao
10 December 2020
Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 managementJennifer L Marté, Nicole J Toney, Lisa Cordes, Jeffrey Schlom, Renee N Donahue, James L Gulley
20 November 2020
Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry surveyNilasha Ghosh, Aidan Tirpack, Karmela K Chan, Anne R Bass
16 October 2020
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologistsMargaret Ottaviano, Marcello Curvietto, Pasquale Rescigno, Marianna Tortora, Giovannella Palmieri, Diana Giannarelli, Michele Aieta, Pasquale Assalone, Laura Attademo, Antonio Avallone, Francesco Bloise, Davide Bosso, Valentina Borzillo, Giuseppe Buono, Giuseppe CalderoniSee the full list of authors
15 October 2020